Women's Health Market Research Reports & Industry Analysis
Viewing women’s health exclusively as a function of sex differences is too narrow, according to the IOM report. It frames women’s health and well-being as a function only of biological factors and how they differ in men and women, and ignores the role of gender, which is affected by broader social and community factors. The IOM finds that there has been inadequate attention paid to the social and environmental factors that, along with biologic risk factors, influence women’s health. Although progress has been made in identifying behavioral determinants of women’s health, such as smoking, diet, and physical activity, few studies have tested ways to modify these determinants in women or examined the effects of social and community factors in specific groups of women. To advance this area of research, the IOM recommends that the National Institutes of Health (NIH) support research on common determinants and risk factors that underlie multiple diseases.
Significant progress has been made in reducing mortality for women from breast cancer, cardiovascular disease and cervical cancer. This can be attributed in part to increased consumer demand and awareness, which has resulted in additional funding and research; improved diagnosis; screening and treatment; and, in the case of cervical cancer, a vaccine.
Women's Health Industry Research & Market Reports
-
Global Premenstrual Syndrome Treatment Market - 2024 - 2031
... (2024-2031). Premenstrual Syndrome is a combination of physical and emotional symptoms, including mood swings, body pain, fatigue, tender breasts, food cravings, fatigue, irritability, and depression. It arises around the end of the luteal phase and ... Read More
-
2025 Pregnancy, Childbirth and The Puerperium Global Market Size & Growth Report with Updated Analysis & Forecasts
... 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling pregnancy, childbirth and the puerperium ... Read More
-
Intrauterine Devices (IUD) Market Report by Product (Hormonal Intrauterine Device, Copper Intrauterine Device), End-Use (Hospitals, Gynaecology Clinics, Community Healthcare, and Others), and Region 2025-2033
... The market is propelled by the rising awareness about long-acting reversible contraception (LARC), significant technological advancements in IUD design and insertion techniques, favorable government initiatives promoting family planning and contraception access. Intrauterine Devices (IUDs) are ... Read More
-
Global Sexual Wellness Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Doxorubicin
... 5.8% over the analysis period 2024-2030. Breast Cancer Application, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$374.1 Million by the end of the analysis period. ... Read More
-
Sex Toys
... CAGR of 7.9% over the analysis period 2024-2030. Adult Vibrators, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$36.8 Billion by the end of the analysis ... Read More
-
Postpartum Hemorrhage (PPH) Treatment Devices
... Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Uterine Balloon Tamponade, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$521.7 ... Read More
-
Colposcopy
... 3.9% over the analysis period 2024-2030. Optical Colposcopy, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$580.3 Million by the end of the analysis period. Growth ... Read More
-
Fertility Testing
... CAGR of 6.3% over the analysis period 2024-2030. Ovulation Predictor Kits, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$571.1 Million by the end of the ... Read More
-
Human Papillomavirus (HPV) Testing
... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$919.4 Million ... Read More
-
Breast Implants
... CAGR of 6.0% over the analysis period 2024-2030. Silicone Implants, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$4.2 Billion by the end of the analysis ... Read More
-
Nursing Breast Pads
... at a CAGR of 5.9% over the analysis period 2024-2030. Reusable Nursing Breast Pads, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$220.4 Million by the ... Read More
-
Ovulation Test
... CAGR of 4.0% over the analysis period 2024-2030. Urine Test, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.2 Billion by the end of the analysis ... Read More
-
Women's Health Rehabilitation Products
... 2030, growing at a CAGR of 1.2% over the analysis period 2024-2030. Orthopedic Rehabilitation Products, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$731.9 Million by ... Read More
-
Family Planning Centers
... at a CAGR of 3.3% over the analysis period 2024-2030. Birth Control Clinics, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$4.5 Billion by the end ... Read More
-
Home Pregnancy Tests (HPT)
... 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Digital Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$597.6 Million by the ... Read More
-
Microwave Ablation
... CAGR of 13.2% over the analysis period 2024-2030. Liver Cancer Application, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$215.5 Million by the end of the ... Read More
-
Cervical Cancer Endoscopic Devices
... 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Optical Colposcopes, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$668.1 Million by the ... Read More
-
Vaginitis Therapeutics
... CAGR of 7.6% over the analysis period 2024-2030. Anti-Bacterial Product, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$2.7 Billion by the end of the analysis ... Read More
-
Breastfeeding Accessories
... CAGR of 6.6% over the analysis period 2024-2030. Breastmilk Storage & Feeding, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$974.4 Million by the end of ... Read More
-
Artificial Insemination
... CAGR of 7.2% over the analysis period 2024-2030. Intrauterine Insemination, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$2.8 Billion by the end of the analysis ... Read More
-
Endometrial Cancer Treatment
... at a CAGR of 5.0% over the analysis period 2024-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$31.3 Billion by the end of the ... Read More
-
Fertility Services
... CAGR of 15.0% over the analysis period 2024-2030. Fresh Non-Donor Fertility Services, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$75.3 Billion by the end of ... Read More
-
Vaginal Moisturizers
... CAGR of 4.2% over the analysis period 2024-2030. Retail Stores End-Use, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$155.2 Million by the end of the ... Read More
-
Vaginal Odor Control Product
... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Intimate Wash, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$3.2 Billion by the ... Read More
Research Assistance
